Safety and tolerability of macitentan in the management of pulmonary arterial hypertension: an update

por Wong, Alexandra K, Channick, Richard N
Publicado 2019

Inhaled treprostinil: a therapeutic review

por Channick, Richard N, Voswinckel, Robert, Rubin, Lewis J
Publicado 2012

Using a knowledge translation program to facilitate guideline‐ and evidence‐based patient management: the PAH‐QuERI Extension Program

por McLaughlin, Vallerie V., Channick, Richard N., Lynum, Karimah S. Bell, Oudiz, Ronald J., Selej, Mona, Tapson, Victor F., Rubin, Lewis J.
Publicado 2022

Quantifying the learning curve for pulmonary thromboendarterectomy

por Sihag, Smita, Le, Bao, Witkin, Alison S., Rodriguez-Lopez, Josanna M., Villavicencio, Mauricio A., Vlahakes, Gus J., Channick, Richard N., Wright, Cameron D.
Publicado 2017

A multicenter, retrospective study of patients with pulmonary arterial hypertension transitioned from parenteral prostacyclin therapy to inhaled iloprost

por Channick, Richard N., Frantz, Robert P., Kawut, Steven M., Palevsky, Harold, Tumuluri, Ramagopal, Sulica, Roxana, Lauto, Paula O., Benton, Wade W., de Boisblanc, Bennett
Publicado 2013

Risk stratification and medical therapy of pulmonary arterial hypertension

por Galiè, Nazzareno, Channick, Richard N., Frantz, Robert P., Grünig, Ekkehard, Jing, Zhi Cheng, Moiseeva, Olga, Preston, Ioana R., Pulido, Tomas, Safdar, Zeenat, Tamura, Yuichi, McLaughlin, Vallerie V.
Publicado 2019

Portopulmonary Hypertension: A Survey of Practice Patterns and Provider Attitudes

por DuBrock, Hilary M., Salgia, Reena J., Sussman, Norman L., Bartolome, Sonja D., Kadry, Zakiyah, Mulligan, David C., Jenkins, Sarah, Lackore, Kandace, Channick, Richard N., Kawut, Steven M., Krowka, Michael J.
Publicado 2019

Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension

por Souza, Rogério, Delcroix, Marion, Galié, Nazzareno, Jansa, Pavel, Mehta, Sanjay, Pulido, Tomás, Rubin, Lewis, Sastry, B. K. S., Simonneau, Gérald, Sitbon, Olivier, Torbicki, Adam, Boyanova, Neli, Chamitava, Liliya, Stein, Claudia, Channick, Richard N.
Publicado 2022

Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension

por Bourge, Robert C, Tapson, Victor F, Safdar, Zeenat, Benza, Raymond L, Channick, Richard N, Rosenzweig, Erika B, Shapiro, Shelley, White, Richard James, McSwain, Christopher Shane, Gotzkowsky, Stephen Karl, Nelsen, Andrew C, Rubin, Lewis J
Publicado 2013

Circulating angiogenic modulatory factors predict survival and functional class in pulmonary arterial hypertension

por Malhotra, Rajeev, Paskin-Flerlage, Samuel, Zamanian, Roham T., Zimmerman, Patrick, Schmidt, Jonathan W., Deng, Donna Y., Southwood, Mark, Spencer, Robert, Lai, Carol S., Parker, William, Channick, Richard N., Morrell, Nicholas W., Elliott, C. Gregory, Yu, Paul B.
Publicado 2013

Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN

por Simonneau, Gérald, Channick, Richard N., Delcroix, Marion, Galiè, Nazzareno, Ghofrani, Hossein-Ardeschir, Jansa, Pavel, Le Brun, Franck-Olivier, Mehta, Sanjay, Perchenet, Loic, Pulido, Tomás, Sastry, B.K.S., Sitbon, Olivier, Souza, Rogério, Torbicki, Adam, Rubin, Lewis J.
Publicado 2015

SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease...

por Galiè, Nazzareno, Jansa, Pavel, Pulido, Tomás, Channick, Richard N., Delcroix, Marion, Ghofrani, Hossein-Ardeschir, Le Brun, Franck-Olivier, Mehta, Sanjay, Perchenet, Loïc, Rubin, Lewis J., Sastry, B.K.S., Simonneau, Gérald, Sitbon, Olivier, Souza, Rogério, Torbicki, Adam
Publicado 2017

Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial

por Souza, Rogério, Channick, Richard N., Delcroix, Marion, Galiè, Nazzareno, Ghofrani, Hossein-Ardeschir, Jansa, Pavel, Le Brun, Franck-Olivier, Mehta, Sanjay, Perchenet, Loïc, Pulido, Tomás, Sastry, B. K. S., Sitbon, Olivier, Torbicki, Adam, Rubin, Lewis J., Simonneau, Gérald
Publicado 2018

Perfusion imaging heterogeneity during NO inhalation distinguishes pulmonary arterial hypertension (PAH) from healthy subjects and has potential as an imaging biomarker

por Winkler, Tilo, Kohli, Puja, Kelly, Vanessa J., Kehl, Ekaterina G., Witkin, Alison S., Rodriguez-Lopez, Josanna M., Hibbert, Kathryn A., Kone, Mamary T., Systrom, David M., Waxman, Aaron B., Venegas, Jose G., Channick, Richard N., Harris, R. Scott
Publicado 2022

Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON study

por Beghetti, Maurice, Channick, Richard N., Chin, Kelly M., Di Scala, Lilla, Gaine, Sean, Ghofrani, Hossein‐Ardeschir, Hoeper, Marius M., Lang, Irene M., McLaughlin, Vallerie V., Preiss, Ralph, Rubin, Lewis J., Simonneau, Gérald, Sitbon, Olivier, Tapson, Victor F., Galiè, Nazzareno
Publicado 2019

The United States Chronic Thromboembolic Pulmonary Hypertension Registry: Protocol for a Prospective, Longitudinal Study

por Kerr, Kim M, Elliott, C Greg, Benza, Raymond L, Channick, Richard N, Chin, Kelly M, Davis, R Duane, Jain, Sonia, LaCroix, Andrea Z, Madani, Michael M, McLaughlin, Vallerie V, Park, Myung H, Tapson, Victor F, Auger, William R
Publicado 2021

TORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertension

por Frantz, Robert P., Benza, Raymond L., Channick, Richard N., Chin, Kelly, Howard, Luke S., McLaughlin, Vallerie V., Sitbon, Olivier, Zamanian, Roham T., Hemnes, Anna R., Cravets, Matt, Bruey, Jean-Marie, Roscigno, Robert, Mottola, David, Elman, Erin, Zisman, Lawrence S., Ghofrani, Hossein-Ardeschir
Publicado 2021

Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry: Enrollment Characteristics and 1-Year Follow-up

por Kerr, Kim M., Elliott, C. Greg, Chin, Kelly, Benza, Raymond L., Channick, Richard N., Davis, R. Duane, He, Feng, LaCroix, Andrea, Madani, Michael M., McLaughlin, Vallerie V., Park, Myung, Robbins, Ivan M., Tapson, Victor F., Terry, Jeffrey R., Test, Victor J., Jain, Sonia, Auger, William R.
Publicado 2021

Significance of autoimmune disease in severe pulmonary hypertension complicating extensive pulmonary fibrosis: a prospective cohort study

por Saggar, Rajeev, Giri, Paresh C., Deng, Chunqin, Johnson, Dana, McCloy, Mary K., Liang, Lloyd, Shaikh, Faisal, Hong, Jason, Channick, Richard N., Shapiro, Shelley S., Lynch, Joseph P., Belperio, John A., Weigt, Samuel S., Ramsey, Allison L., Ross, David J., Sayah, David M., Shino, Michael Y., Derhovanessian, Ariss, Sherman, Alexander E., Saggar, Rajan
Publicado 2021